ArticleFrontiers in cardiovascular medicine2022

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study.

Marta Jiménez-Blanco Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.